[1]郭永铁.与CA125联合的检测指标在妇科良性病变中的应用[J].国际放射医学核医学杂志,2009,33(2):97-99.[doi:10.3760/cma.j.issn.1673-4114.2009.02.010]
　GUO Yong-tie.CA125 detection and the united indicators in benign gynecological diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):97-99.[doi:10.3760/cma.j.issn.1673-4114.2009.02.010]
点击复制

与CA125联合的检测指标在妇科良性病变中的应用(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
33
期数:
2009年第2期
页码:
97-99
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
CA125 detection and the united indicators in benign gynecological diseases
作者:
郭永铁
天津中医药大学第一附属医院检验科, 天津 300193
Author(s):
GUO Yong-tie
Department of Clinical Laboratory, First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
关键词:
CA125抗原; 诊断实验; 常规; 生殖器疾病; 女性
Keywords:
CA-125 antigen; Diagnostic tests;  routine; Genital diseases;  female
DOI:
10.3760/cma.j.issn.1673-4114.2009.02.010
摘要:
妇科病症状隐蔽、起病缓慢,尤其是妇科良性病变,常常被患者忽视.症状的不典型、与其他慢性病的叠加,容易造成误诊、漏诊.糖类抗原125(CA125)检测在妇科良性病变诊断中有重要价值,联合其他检测指标,可提高诊断特异性.该文对与CA125联合检测的各项指标在妇科良性病变的诊断和预后中的作用进行简要综述.
Abstract:
Because of the hidden symptoms and slow onset,benign gynecological disease is often ignored.Atypical symptoms and superposition with other chronic diseases will result in misdiagnosis and missed diagnosis.CA125 has significant value in benign gynecological diseases diagnosis.Joint detection with other indicators can elevate the diagnosis specificity.This review summarizes indicators combined with CA125 detection in benign gynecological disease diagnosis and prognosis.

参考文献/References:

[1] 徐怡,黄艳春,雷君,等.血清CA125检测对恶性肿瘤的临床诊断价值.新疆医科大学学报,2007,30(1):67-71.
[2] Nagler R, Bahar G, Shpitzer T, et al. Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer. Clin Cancer Res, 2006, 12(13):3979-3984.
[3] Dede M, Gungor S, Yenen MC, et al. CA19-9 may have clinical significance in mature cystic teratomas of the ovary. Int J Gynecol Cancer, 2006, 16(1):189-193.
[4] 尚慧玲,王博蔚,李荷莲.CA125及CA19-9抗原在子宫内膜异位症组织中的表达及意义.吉林大学学报(医学版),2005,31(2):296-298.
[5] Guerriero S, Ajossa S, Paoletti AM, et al. Tumormarkers and transvaginal ultrasonography in the diagnosis of endometrioma. Obstet Gynecol, 1996, 88(3):403-407.
[6] Toki T, Kubota J, Lu X, et al analysis of CA125, CA19-9, and Ki-67 in stage Ⅲ or Ⅳ endometriosis:positive correlation between serum CA125 level and endometriotic epithelial cell proliferation. Acta Obstet Gynecol Scand, 2000, 79(9):771-776.
[7] Harada T, Kubota T, Aso T. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril, 2002, 78(4):733-739.
[8] 刘爱民.血清CA125和CA19-9水平对子宫内膜异位症诊断价值的探讨.放射免疫学杂志,2008,21(1):11-13.
[9] 丰有吉,沈铿.妇产科学.北京:人民卫生出版社,2006:3.
[10] Gracia CR, Barnhart KT. Diagnosing ectopic pregnancy:decision analysis comparing six strategies. Obstet Gynecol, 2001, 97(3):464-470.
[11] Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistocytosis. Hematology Am Soe Hematol Educ Program, 2005:82-88.
[12] 镡丽霞.β-HCG、CA125联合监测在异位妊娠保守治疗中的价值.疑难病杂志,2007,6(8):492-493.
[13] 孙祥秀,徐永萍.抗子宫内膜抗体对大鼠不孕及自然流产的影响.生殖与避孕,2007,27(4):255-259.
[14] Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometrisis. Fertil Steril, 2001, 75(1):1-10.
[15] 黄晓英,曾传蓉.Ca125和EMAb联合检测在腺肌病与子宫肌瘤鉴别诊断中的应用.检验医学与临床,2008,5(6):353-354.
[16] Chattopadhyay S, Chakraborty NG, Mukherji B. Regulatory T cells and tumor immunity. Cancer Immunol Immunother, 2005, 54(12):1153-1161.
[17] 张顺斌.血清CA125和TGF-β1检测对子宫内膜异位症诊断价值的探讨.放射免疫学杂志,2008,21(2):173-174.

备注/Memo

备注/Memo:
收稿日期:2008-11-24。
更新日期/Last Update: 1900-01-01